These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 34246971

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Synthesis, and In Vitro and In Silico α-Glucosidase Inhibitory Studies of 5-Chloro-2-Aryl Benzo[d]thiazoles.
    Shah S, Arshia, Javaid K, Zafar H, Mohammed Khan K, Khalil R, Ul-Haq Z, Perveen S, Iqbal Choudhary M.
    Bioorg Chem; 2018 Aug; 78():269-279. PubMed ID: 29614438
    [Abstract] [Full Text] [Related]

  • 23. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
    Kazmi M, Zaib S, Ibrar A, Amjad ST, Shafique Z, Mehsud S, Saeed A, Iqbal J, Khan I.
    Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
    [Abstract] [Full Text] [Related]

  • 24. Design, synthesis and in vitro α-glucosidase inhibition of novel dihydropyrano[3,2-c]quinoline derivatives as potential anti-diabetic agents.
    Nikookar H, Mohammadi-Khanaposhtani M, Imanparast S, Faramarzi MA, Ranjbar PR, Mahdavi M, Larijani B.
    Bioorg Chem; 2018 Apr; 77():280-286. PubMed ID: 29421703
    [Abstract] [Full Text] [Related]

  • 25. An efficient and targeted synthetic approach towards new highly substituted 6-amino-pyrazolo[1,5-a]pyrimidines with α-glucosidase inhibitory activity.
    Peytam F, Adib M, Shourgeshty R, Firoozpour L, Rahmanian-Jazi M, Jahani M, Moghimi S, Divsalar K, Faramarzi MA, Mojtabavi S, Safari F, Mahdavi M, Foroumadi A.
    Sci Rep; 2020 Feb 13; 10(1):2595. PubMed ID: 32054916
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition.
    Nasli-Esfahani E, Mohammadi-Khanaposhtani M, Rezaei S, Sarrafi Y, Sharafi Z, Samadi N, Faramarzi MA, Bandarian F, Hamedifar H, Larijani B, Hajimiri M, Mahdavi M.
    Arch Pharm (Weinheim); 2019 Aug 13; 352(8):e1900034. PubMed ID: 31330079
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Design, synthesis, molecular docking, and in vitro α-glucosidase inhibitory activities of novel 3-amino-2,4-diarylbenzo[4,5]imidazo[1,2-a]pyrimidines against yeast and rat α-glucosidase.
    Peytam F, Takalloobanafshi G, Saadattalab T, Norouzbahari M, Emamgholipour Z, Moghimi S, Firoozpour L, Bijanzadeh HR, Faramarzi MA, Mojtabavi S, Rashidi-Ranjbar P, Karima S, Pakraad R, Foroumadi A.
    Sci Rep; 2021 Jun 07; 11(1):11911. PubMed ID: 34099819
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as α-Glucosidase Inhibitors.
    Gong Z, Xie Z, Qiu J, Wang G.
    Molecules; 2017 Oct 30; 22(11):. PubMed ID: 29084182
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Synthesis, in vitro evaluation and molecular docking studies of biscoumarin thiourea as a new inhibitor of α-glucosidases.
    Zawawi NK, Taha M, Ahmat N, Ismail NH, Wadood A, Rahim F, Rehman AU.
    Bioorg Chem; 2015 Dec 30; 63():36-44. PubMed ID: 26432614
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.
    Khan KM, Rahim F, Wadood A, Kosar N, Taha M, Lalani S, Khan A, Fakhri MI, Junaid M, Rehman W, Khan M, Perveen S, Sajid M, Choudhary MI.
    Eur J Med Chem; 2014 Jun 23; 81():245-52. PubMed ID: 24844449
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.